Published in Clin Pharmacol Ther on March 18, 2009
Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide | NCT01947699
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ (2015) 3.06
Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol (2014) 2.11
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol (2011) 1.36
Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos (2013) 1.27
Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos (2010) 1.09
Clinical therapeutics in pregnancy. J Biomed Biotechnol (2011) 1.08
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics. Br J Clin Pharmacol (2012) 1.07
Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol (2009) 1.02
Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos (2010) 0.96
Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation (2013) 0.91
Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. Br J Clin Pharmacol (2014) 0.91
Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice. Drug Metab Dispos (2012) 0.90
The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. Am J Obstet Gynecol (2012) 0.88
The National Children's Study: a golden opportunity to advance the health of pregnant women. Am J Public Health (2009) 0.88
The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity. Brain Sci (2013) 0.88
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol (2012) 0.87
Increased glyburide clearance in the pregnant mouse model. Drug Metab Dispos (2010) 0.85
The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration. Am J Obstet Gynecol (2013) 0.82
Gestational diabetes mellitus management with oral hypoglycemic agents. Semin Perinatol (2014) 0.80
Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci (2011) 0.80
Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci (2009) 0.80
Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. PLoS One (2014) 0.79
Adiponectin: are measurements clinically useful in pregnancy? Diabetes Care (2013) 0.79
Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug? Obstet Gynecol (2012) 0.78
Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age. J Pharmacol Exp Ther (2014) 0.78
Identification of CYP3A7 for glyburide metabolism in human fetal livers. Biochem Pharmacol (2014) 0.77
Pharmacogenetics and individualizing drug treatment during pregnancy. Pharmacogenomics (2014) 0.75
Oral hypoglycemic agents: do the ends justify the means? Matern Health Neonatol Perinatol (2015) 0.75
Examining the Starting Dose of Glyburide in Gestational Diabetes. Am J Perinatol (2015) 0.75
Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer. Diabet Med (2017) 0.75
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med (2005) 16.55
Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol (1982) 9.60
Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med (2008) 6.90
Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA (2002) 5.26
Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med (1995) 4.79
A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med (2000) 4.13
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05
Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care (1992) 2.90
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol (2005) 2.58
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther (2007) 2.38
Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol (1999) 2.29
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes (2006) 2.20
Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab (2001) 2.11
Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab (2004) 2.04
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes. Clin Pharmacol Ther (2002) 2.01
The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng (2002) 1.88
Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol (1991) 1.75
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol (1991) 1.70
Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes (2005) 1.62
Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab (2005) 1.50
Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol (1990) 1.48
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther (2002) 1.42
Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab (2001) 1.41
Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev (2003) 1.37
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol (1997) 1.30
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharmacol (2003) 1.15
The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care (2007) 1.08
Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes (1991) 1.06
Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab (2001) 1.05
Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Xenobiotica (2004) 1.04
Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. Br J Clin Pharmacol (1990) 1.00
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol (1994) 0.98
Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res (1990) 0.97
Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. Biochem Pharmacol (2006) 0.97
Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol (2006) 0.97
Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol (2004) 0.97
Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care (1994) 0.96
Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care (1991) 0.96
In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide. Clin Pharmacol Ther (2002) 0.93
CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects. Clin Pharmacol Ther (2005) 0.92
Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Diabetes Care (1988) 0.89
Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.88
Population pharmacokinetics of glyburide in patients with well-controlled diabetes. Pharmacotherapy (1998) 0.87
Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol (2004) 0.84
[Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects]. Yao Xue Xue Bao (2005) 0.78
Large-scale temporal gene expression mapping of central nervous system development. Proc Natl Acad Sci U S A (1998) 9.06
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med (1993) 8.03
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82
Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med (2001) 3.81
The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg (1998) 3.32
Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care (1999) 3.16
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05
Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1993) 2.96
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1998) 2.90
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism (1998) 2.65
The Preterm Prediction Study: association of cesarean delivery with increases in maternal weight and body mass index. Am J Obstet Gynecol (1997) 2.57
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene (2000) 2.55
Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev (2006) 2.52
Association between method of delivery and maternal rehospitalization. JAMA (2000) 2.49
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther (2007) 2.38
Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A (1994) 2.34
Global identifiability of nonlinear models of biological systems. IEEE Trans Biomed Eng (2001) 2.33
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33
Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol (1999) 2.26
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia (2005) 2.23
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
Cluster analysis and data visualization of large-scale gene expression data. Pac Symp Biocomput (1998) 2.20
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG (2014) 2.20
Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. J Clin Anesth (1993) 2.18
Effect of changes in maternal age, parity, and birth weight distribution on primary cesarean delivery rates. JAMA (1994) 2.17
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest (1998) 2.16
Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc (1992) 2.16
Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1998) 2.16
Generalized sensitivity functions in physiological system identification. Ann Biomed Eng (1999) 2.15
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol (2008) 2.13
Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity (2000) 2.10
Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol (1998) 2.05
PlexinA2 and semaphorin signaling during cardiac neural crest development. Development (2001) 2.02
The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1999) 2.01
Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol (1995) 1.92
Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA (2001) 1.92
Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry (1994) 1.91
The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health (1998) 1.90
The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol (1998) 1.85
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83
An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol (2000) 1.82
Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J (2001) 1.79
Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg (1995) 1.79
The corticofugal system for hearing: recent progress. Proc Natl Acad Sci U S A (2000) 1.79
The neuroanatomy, neurophysiology, and neurochemistry of pain, stress, and analgesia in newborns and children. Pediatr Clin North Am (1989) 1.77
Music for pain relief. Cochrane Database Syst Rev (2006) 1.76
Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol (1995) 1.75
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1999) 1.75
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med (1994) 1.70
Prontosil in Erysipelas. Br Med J (1937) 1.70
Comparative effects of p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem Pharmacol (1970) 1.69
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol (1980) 1.69
Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia (2007) 1.67
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Obstetric determinants of neonatal survival: antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. Am J Obstet Gynecol (1999) 1.66
Ethics instruction at schools of public health in the United States. Association of Schools of Public Health Education Committee. Am J Public Health (1999) 1.64
The mechanisms of action of reproductive toxins. Am J Ind Med (1983) 1.64
Culturally appropriate nutrition education improves infant feeding and growth in rural Sichuan, China. J Nutr (2000) 1.63
Myxococcus xanthus dif genes are required for biogenesis of cell surface fibrils essential for social gliding motility. J Bacteriol (2000) 1.61
Modular closed-loop control of diabetes. IEEE Trans Biomed Eng (2012) 1.61
Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci U S A (1998) 1.59
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet (1978) 1.59
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
The influence of sporadic anovulation on hormone levels in ovulatory cycles. Hum Reprod (2013) 1.57
High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice. J Thromb Haemost (2007) 1.57
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
Sulphanilamide in the Treatment of Erysipelas. Br Med J (1937) 1.56
Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol (2000) 1.56
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Isolated cortical vein thrombosis: a widely variable clinicoradiological spectrum. Eur Neurol (2013) 1.54
Serotonin syndrome associated with triptan monotherapy. N Engl J Med (2008) 1.54
A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res (2000) 1.52
Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics (2005) 1.52
Clinical pharmacokinetics of zidovudine. An overview of current data. Clin Pharmacokinet (1989) 1.52
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52